We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

77 ELEKTRONIKA

Develops, manufactures, and markets fully automated and semi-automated urine analyzers, blood glucose meters, rapid t... read more Featured Products: More products

Download Mobile App





77 Elektronika Showcases Latest Developments in Urinalysis

By LabMedica International staff writers
Posted on 08 Feb 2024

At Medlab Middle East 2024, 77 Elektronika (Budapest, Hungary) is demonstrating how its high-end urinalysis products can boost laboratory efficiency. More...

77 Elektronika is showcasing its full product range, including its latest developments in urinalysis, such as the new pediatric measurement mode of LabUMat 2 and UriSed 3 PRO or the brand new research use only (RUO) feature of the UriSed mini device. Urine sediment analysis is very sensitive to inhomogeneous particle distribution in the sample: some urine sediment particles subside quickly and hence, proper mixing is crucial to obtain reliable results. 77 Elektronika has implemented sample level adaptive mixing procedure into its fully automated UriSed technology instruments, the UriSed 2 and UriSed 3 PRO. During sample mixing some urine is aspirated from the test tube and pushed back again. This “sip and spit” mixing is repeated to make sure that all particles are homogenized. This standardized method provides consistent results quickly and effectively.

Visitors to the 77 Elektronika booth at Medlab Middle East 2024 can experience UriSed Technology which offers a premium category solution for sediment analysis, providing high-resolution whole-view field microscopic images in an automatic and reproducible way. The goal of UriSed Technology is to make urinary sediment analysis faster, more reliable, and more operator-independent, eliminating the need for manual microscopy while adhering to gold standard guidelines. With UriSed technology, laboratories can achieve accurate and dependable results in just a fraction of the time it takes with traditional methods. The technology provides a detailed analysis of urine samples, detecting red and white blood cells, epithelial cells, bacteria, and other microscopic elements. This makes it an essential tool for diagnosing various medical conditions, including urinary tract infections, kidney diseases, and many more. The fully automated UriSed 3 PRO urine sediment analyzer provides automatic and reproducible results, ensuring that each sample is analyzed with the same precision and accuracy. Also on display at the event is the UriSed mini device which now comes with the brand new feature of Body Fluid Measurement mode which is available only for RUO mode and not for diagnostic purposes. The two measurement phases of stained and unstained samples enable a wider range of sample analysis that includes various body fluid types.

Related Links:
77 Elektronika


New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
UHF RFID Tag & Inlay
AD-327 U9 ETSI Pure 95
New
Enterovirus Test
Quanty Enterovirus System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
MEDLAB 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.